488 related articles for article (PubMed ID: 7682650)
1. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
Chaki S; Inagami T
Mol Pharmacol; 1993 Apr; 43(4):603-8. PubMed ID: 7682650
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
Baltrons MA; García A
J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
[TBL] [Abstract][Full Text] [Related]
3. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
4. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Díaz-Troya S; Najib S; Sánchez-Margalet V
Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide modulation of agonist-evoked intracellular Ca2+ release in neurosecretory PC-12 cells: inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I.
Clementi E; Vecchio I; Sciorati C; Nisticò G
Mol Pharmacol; 1995 Mar; 47(3):517-24. PubMed ID: 7535379
[TBL] [Abstract][Full Text] [Related]
6. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells.
Ujiie K; Hogarth L; Danziger R; Drewett JG; Yuen PS; Pang IH; Star RA
J Pharmacol Exp Ther; 1994 Aug; 270(2):761-7. PubMed ID: 7915320
[TBL] [Abstract][Full Text] [Related]
7. Regulation by calcium of the nitric oxide/cyclic GMP system in cerebellar granule cells and astroglia in culture.
Baltrons MA; Saadoun S; Agulló L; García A
J Neurosci Res; 1997 Aug; 49(3):333-41. PubMed ID: 9260744
[TBL] [Abstract][Full Text] [Related]
8. AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity.
Andresen BT; Shome K; Jackson EK; Romero GG
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F763-70. PubMed ID: 15572519
[TBL] [Abstract][Full Text] [Related]
9. The cloned neurotensin receptor mediates cyclic GMP formation when coexpressed with nitric oxide synthase cDNA.
Slusher BS; Zacco AE; Maslanski JA; Norris TE; McLane MW; Moore WC; Rogers NE; Ignarro LJ
Mol Pharmacol; 1994 Jul; 46(1):115-21. PubMed ID: 7520123
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
Zhao X; Li X; Trusa S; Olson SC
Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
12. Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells.
Sharma R; Sharma M; Vamos S; Savin VJ; Wiegmann TB
J Lab Clin Med; 2001 Jul; 138(1):40-9. PubMed ID: 11433227
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.
Hakam AC; Hussain T
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1430-6. PubMed ID: 16380464
[TBL] [Abstract][Full Text] [Related]
14. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
[TBL] [Abstract][Full Text] [Related]
15. BAY 41-2272, a potent activator of soluble guanylyl cyclase, stimulates calcium elevation and calcium-activated potassium current in pituitary GH cells.
Liu YC; Wu SN
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1078-87. PubMed ID: 16445574
[TBL] [Abstract][Full Text] [Related]
16. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.
Hirata Y; Emori T; Eguchi S; Kanno K; Imai T; Ohta K; Marumo F
J Clin Invest; 1993 Apr; 91(4):1367-73. PubMed ID: 7682570
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide induces transient Ca2+ changes in endothelial cells independent of cGMP.
Volk T; Mäding K; Hensel M; Kox WJ
J Cell Physiol; 1997 Sep; 172(3):296-305. PubMed ID: 9284949
[TBL] [Abstract][Full Text] [Related]
18. Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium.
Parkinson SJ; Jovanovic A; Jovanovic S; Wagner F; Terzic A; Waldman SA
Biochemistry; 1999 May; 38(20):6441-8. PubMed ID: 10350462
[TBL] [Abstract][Full Text] [Related]
19. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
20. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
